2002
DOI: 10.1590/s0102-76382002000100010
|View full text |Cite
|
Sign up to set email alerts
|

Estudo comparativo das estimulações ventricular direita e biventricular no pós-operatório de revascularização miocárdica

Abstract: das estimulações ventricular direita e biventricular no pós-operatório de revascularização miocárdica. Rev Bras Cir Cardiovasc 2002; 17(1): 61-72. Rev Bras Cir Cardiovasc 2002; 17(1): 61-72. Trabalho realizado no Hospital São Lucas da PUCRS -Porto Alegre, RS, Brasil. Recebido para publicação em fevereiro de 2001. das estimulações ventricular direita e biventricular no pós-operatório de revascularização miocárdica. Rev Bras Cir Cardiovasc 2002; 17(1): 61-72.RESUMO: Objetivo: Nos anos recentes, a ressincroniz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2006
2006

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
(47 reference statements)
0
1
0
Order By: Relevance
“…26 In such cases, heparin remains the standard treatment, although there is mounting evidence in the literature in favor of thrombolytic therapy, followed by anticoagulation. 12,[27][28][29][30][31][32][33][34] There have also been reports of patients with DVT who were successfully treated with tissue plasminogen activator as an alternative to streptokinase, although most of the time this agent has been infused locoregionally (catheter-directed) instead of systemically. 35 The placement of a vena cava fi lter above the level of the thrombosis may occasionally be considered, although in view of the high complication rates observed with most of these devices, their use has most often been reserved for patients experiencing recurrent pulmonary thromboembolism despite optimal anticoagulation.…”
Section: Discussionmentioning
confidence: 99%
“…26 In such cases, heparin remains the standard treatment, although there is mounting evidence in the literature in favor of thrombolytic therapy, followed by anticoagulation. 12,[27][28][29][30][31][32][33][34] There have also been reports of patients with DVT who were successfully treated with tissue plasminogen activator as an alternative to streptokinase, although most of the time this agent has been infused locoregionally (catheter-directed) instead of systemically. 35 The placement of a vena cava fi lter above the level of the thrombosis may occasionally be considered, although in view of the high complication rates observed with most of these devices, their use has most often been reserved for patients experiencing recurrent pulmonary thromboembolism despite optimal anticoagulation.…”
Section: Discussionmentioning
confidence: 99%